Achievements
- Bristol-Myers Squibb “Freedom to Discover Award”
- the ASBMB-Avanti Award in Lipids, the Roy Greep Award for outstanding research of the Endocrine Society
- the ASBMB-Merck Award for outstanding research (shared with Dr. Walther).
- Election to American Society for Clinical Investigation, the Association of American Physicians, and Fellow of the American Society for Cell Biology
View a full listing of Robert Farese’s journal articles.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Robert Farese discloses the following relationships and financial interests:
-
Bluefield Project to Cure FTD
Fiduciary Role / Position; Professional Services and Activities (Uncompensated) -
Genentech
Professional Services and Activities
-
Gladstone Institutes
Intellectual Property Rights
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures